Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients ...
MARC McKee shed a life-changing nine stone in just 10 months on fat jabs, now revealing the injection spot he believes works ...
After Colin Egglesfield was diagnosed with cancer for a third time in 2024, the actor and motivational speaker shared an ...
MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...
The phase three clinical trial reached a milestone with its first American participant receiving treatment, advancing research into improved diagnostic approaches for prostate cancer detection.
Q. You recently wrote that testosterone does not increase the risks for heart attacks. But you overlooked the real risk of testosterone therapy: cancer!
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...
The patients received Lutetium (177Lu) rhPSMA-10.1 Injections at both St Bartholomew's Hospital, London, and The James Cook University Hospital, Middlesbrough -- Lutetium (177Lu) rhPSMA-10.1 Injection ...
Q. You recently wrote that testosterone does not increase the risk for heart attacks. But you overlooked the real risk of ...
Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...
You know the drill by now. You're sitting in the purgatory of the service center waiting room. Precisely 63 minutes into your wait, the service adviser walks out with a clipboard and calls your name — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results